fashion -WSS

fashion

author：fashion 2025-09-28 01:40:22 - browse：1

A judge ruled that Welsh Carson won't have to face antitrust allegations about its anesthesiology practice. Adobe

Welsh, Carson, Anderson & Stowe has wiggled out of the grasp of the Federal Trade Commission, but the private equity firm’s anesthesia company, U.S. Anesthesia Partners, still must face the agency’s antitrust case, a judge ruled last week.

The FTC alleged last year that the anesthesiology network monopolized markets in Texas to drive up prices, but took the unusual step of attaching Welsh Carson as a defendant with USAP. Dismissing Welsh Carson from the case was a victory for the private equity firm and, more broadly, other firms worried that the Biden administration would try to hold them responsible for anything their portfolio companies do.

But the allegations against USAP didn’t disappear, which will keep up scrutiny on companies that have made a push to acquire numerous physician groups.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily market-moving biopharma analysis — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： How Long Island became the ‘eugenics capital of the world’

WSS

In science, is the line between industry and academia shifting?

Sea level rise could wash away turtle breeding grounds around the world, researchers say

Psilocybin's anti

Radiation, mainstay of cancer treatment, begins a fade

Complete sequence of Y chromosome published for first time

Psilocybin's anti

focus

fashion

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily market-moving biopharma analysis — by subscribing to STAT+.

hotspot

Cancer drug shortages should be causing more outrage

CDC advisory panel says seniors 'may' get RSV vaccine

23andMe had bad news about my health. I wish a person had delivered it

Why more medical students aren't specializing in primary care

How one medical school became remarkably diverse

Diversity in medical illustrations gets boost from Chidiebere Ibe

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Drug firms test therapies to halt Alzheimer’s before symptoms arise

In age of alternative facts, a scholarly course on calling out crap

Sea level rise could wash away turtle breeding grounds around the world, researchers say

hotspot

Science's Marcia McNutt, trailblazer for women, encounters sexism scandal

CDC advisory panel says seniors 'may' get RSV vaccine

Living organ donors deserve priority status for transplants

Why more medical students aren't specializing in primary care

Complete sequence of Y chromosome published for first time

FDA panel gives mixed vote on blood pressure devices

hotspot

explore

explore

entertainment